Kathrin Schramm

975 total citations
15 papers, 309 citations indexed

About

Kathrin Schramm is a scholar working on Molecular Biology, Clinical Psychology and Cancer Research. According to data from OpenAlex, Kathrin Schramm has authored 15 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Clinical Psychology and 3 papers in Cancer Research. Recurrent topics in Kathrin Schramm's work include Psychiatric care and mental health services (3 papers), interferon and immune responses (2 papers) and Pluripotent Stem Cells Research (2 papers). Kathrin Schramm is often cited by papers focused on Psychiatric care and mental health services (3 papers), interferon and immune responses (2 papers) and Pluripotent Stem Cells Research (2 papers). Kathrin Schramm collaborates with scholars based in Germany, United States and Austria. Kathrin Schramm's co-authors include Peter Lichter, Stefan M. Pfister, David Jones, Jan Gronych, Marc Zapatka, Christiane B. Knobbe‐Thomsen, Jelena Belic, Volker Hovestadt, Branden S. Moriarity and Paul A. Northcott and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Kathrin Schramm

11 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathrin Schramm Germany	7	221	56	52	43	43	15	309
Freja K. Ekman United States	5	351 1.6×	128 2.3×	49 0.9×	26 0.6×	6 0.1×	7	402
Paolo Petazzi Spain	13	320 1.4×	196 3.5×	6 0.1×	64 1.5×	65 1.5×	21	460
Kana Hosoki Japan	10	392 1.8×	134 2.4×	46 0.9×	29 0.7×	48 1.1×	13	490
Ejona Rusha Germany	6	257 1.2×	56 1.0×	28 0.5×	7 0.2×	47 1.1×	9	309
Saša Šviković United Kingdom	10	428 1.9×	47 0.8×	5 0.1×	95 2.2×	39 0.9×	12	480
Toshiyuki Maeda Japan	11	396 1.8×	151 2.7×	11 0.2×	44 1.0×	47 1.1×	13	563
Céline Cluzeau United States	12	274 1.2×	57 1.0×	11 0.2×	8 0.2×	15 0.3×	15	529
Val Davison United Kingdom	7	199 0.9×	120 2.1×	98 1.9×	21 0.5×	53 1.2×	10	368
Michelle M. Simon United Kingdom	7	169 0.8×	46 0.8×	16 0.3×	13 0.3×	19 0.4×	15	253
Cristina Valensisi United States	9	335 1.5×	103 1.8×	44 0.8×	24 0.6×	26 0.6×	10	434

Countries citing papers authored by Kathrin Schramm

Since Specialization

Citations

This map shows the geographic impact of Kathrin Schramm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathrin Schramm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathrin Schramm more than expected).

Fields of papers citing papers by Kathrin Schramm

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathrin Schramm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathrin Schramm. The network helps show where Kathrin Schramm may publish in the future.

Co-authorship network of co-authors of Kathrin Schramm

This figure shows the co-authorship network connecting the top 25 collaborators of Kathrin Schramm. A scholar is included among the top collaborators of Kathrin Schramm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathrin Schramm. Kathrin Schramm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Schramm, Kathrin, Stefan Schönberger, Ines B. Brecht, et al.. (2025). Melanoma of the Choroid and Ciliary Body in Children: Remission of Metastatic Melanoma of the Choroid After Treatment With Chemotherapy and Immune Checkpoint Inhibition. Pediatric Blood & Cancer. 73(2). e32147–e32147.

Blattner-Johnson, Mirjam, Dominik Sturm, Steffen Hirsch, et al.. (2024). HGG-21. DISTRIBUTION AND MUTATIONAL PATTERNS OF TP53 ALTERATIONS ACROSS SUBTYPES OF PEDIATRIC HIGH-GRADE GLIOMAS. Neuro-Oncology. 26(Supplement_4). 0–0.

Mayr, Lisa, Maria T. Schmook, Adalbert Raimann, et al.. (2024). Feasibility and antitumour activity of the FGFR inhibitor erdafitnib in three paediatric CNS tumour patients. Pediatric Blood & Cancer. 71(3). e30836–e30836. 8 indexed citations

Afanasyeva, Elena, M. Schneider, Christopher Schröder, et al.. (2024). A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma. Communications Biology. 7(1). 919–919. 2 indexed citations

Thorwarth, Anne, Kerstin Haase, Claudia Röefzaad, et al.. (2022). Genomic Evolution and Personalized Therapy of an Infantile Fibrosarcoma Harboring anNTRKOncogenic Fusion. JCO Precision Oncology. 6(6). e2100283–e2100283. 3 indexed citations

Peterziel, Heike, Kathrin Schramm, Sina Oppermann, et al.. (2022). Multiomics analysis of pediatric solid tumors within the INFORM precision oncology study: From functional drug profiling to biomarker identification.. Journal of Clinical Oncology. 40(16_suppl). 10036–10036.

Thieme, Anne, Katja Maurus, Karen Ernestus, et al.. (2021). Secondary Biphenotypic Acute Leukemia Following Rosai-Dorfman-Disease A Coincidence?. Klinische Pädiatrie. 234(3). 169–171.

Tilburg, Cornelis M. van, Elke Pfaff, Kristian W. Pajtler, et al.. (2020). The pediatric precision oncology study INFORM: Clinical outcome and benefit for molecular subgroups.. Journal of Clinical Oncology. 38(18_suppl). LBA10503–LBA10503. 8 indexed citations

Schramm, Kathrin, Murat Iskar, Natalie Jäger, et al.. (2019). DECIPHER pooled shRNA library screen identifies PP2A and FGFR signaling as potential therapeutic targets for diffuse intrinsic pontine gliomas. Neuro-Oncology. 21(7). 867–877. 24 indexed citations

10.

Zuckermann, Marc, Volker Hovestadt, Christiane B. Knobbe‐Thomsen, et al.. (2015). Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling. Nature Communications. 6(1). 7391–7391. 220 indexed citations

11.

Mauceri, Daniela, Anna M. Hagenston, Kathrin Schramm, Ursula Weiß, & Hilmar Bading. (2015). Nuclear Calcium Buffering Capacity Shapes Neuronal Architecture. Journal of Biological Chemistry. 290(38). 23039–23049. 22 indexed citations

12.

Zuckermann, Marc, Volker Hovestadt, Christiane B. Knobbe‐Thomsen, et al.. (2015). Abstract PR02: Somatic CRISPR/Cas9-mediated tumor suppressor disruption enables versatile brain tumor modeling. Cancer Research. 75(23_Supplement). PR02–PR02. 1 indexed citations

13.

Längle, Gerhard, et al.. (2002). Der Tübinger Bogen zur Behandlungszufriedenheit (TÜBB 2000). Psychiatrische Praxis. 29(2). 83–89. 2 indexed citations

14.

Längle, Gerhard, et al.. (2002). Der Tübinger Bogen zur Behandlungszufriedenheit (TÜBB 2000) - Ein Instrument zur Qualitätsentwicklung in psychiatrischen Kliniken -. Psychiatrische Praxis. 29(2). 83–89. 11 indexed citations

15.

Längle, Gerhard, et al.. (2002). [The Tübingen questionnaire of treatment satisfaction].. Psychiatrische Praxis. 29(2). 83–9. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact